Abaxis said it bought QCR & Trio Diagnostics, its distribution partner for veterinary products in the U.K. and Ireland.
The deal closed on Nov. 17, Abaxis said. Financial terms were not disclosed.
By Chris Walker
The U.S. Defense Dept. issued $83.9 million worth of contracts to 4 medical device companies, according to the agency’s daily press release.
Covidien Plc.’s (NYSE:COV) board of directors approved a $2 billion stock repurchase program today.
"The board’s approval of this share repurchase program reflects its confidence in the continued growth of Covidien’s business, our sustainable free cash flow and our commitment to enhance shareholder value," president & CEO José Almeida said in a press release.
Edwards Lifesciences Corp. (NYSE:EW) landed a new four-year $500 million credit facility after canceling a prior one a couple months early.
The old facility was a five-year deal, also for $500 million, that was scheduled to mature September 29, 2011.
MassDevice keeps a close eye on public medical device companies, tracking their quarterly sales and earnings reports. For the most recent filings, check out our Earnings Roundup, where we collect each quarter’s reports.
Here’s a quick rundown of a few releases over the past couple days:
Abaxis Inc. (NSDQ:ABAX) posted third-quarter sales of $31 million for the three months ended Dec. 31, 2009, up 15 percent compared with $27 million during the same period in 2008. Net income rose 2.2 percent to $3.43 million, compared with $3.36 million during Q3 2008: